- Home
- Investing
- Stocks
The Dow Jones Industrial Average outperformed on strength in cyclical stocks.
By
Karee Venema
published
8 January 2026
in News
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
Share Share by:- Copy link
- X
It was a mixed session for stocks on Thursday, with market participants reducing exposure to tech names and boosting bets on cyclical plays. The main indexes failed to make any major moves, though, as caution took hold ahead of a key jobs report and the start of fourth-quarter earnings season.
Technology was the worst-performing S&P 500 sector today, shedding 1.6% as several Magnificent 7 stocks slumped. Most notable was Nvidia's (NVDA) 2.2% drop, which came after Stifel analyst Ruben Roy said following an investor meeting with the chipmaker's chief financial officer, Colette Kress, that the company is "still cautious" toward China.
Track all markets on TradingViewWhile President Donald Trump said last month that he would allow sales of Nvidia's H200 artificial intelligence (AI) chips to China in exchange for a 25% cut of revenue, several media reports suggest Beijing has asked tech companies not to buy them.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
CLICK FOR FREE ISSUE
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Sign up"We would say the tone remained optimistic around China, but the statements remained prudently conservative," says Ruben. "In our view, China is a swing factor to the positive for NVDA, with sell-side and buy-side models not counting on these sales just yet."
Ruben has a Buy rating on the blue chip stock and a $250 price target, representing implied upside of 35% to current levels.
Apple extends losing streak to seven
Thursday's loss made Nvidia one of the worst Dow Jones stocks on the day, as was fellow Mag 7 member Apple (AAPL) was not far behind.
AAPL stock dropped 0.5% for its seventh straight daily loss. It's now down 5% for the year to date.
Track all markets on TradingViewAmid this pullback, Apple has lost its ranking as the world's second-biggest company by market cap. That honor now goes to Alphabet (GOOGL, +1.1%), whose 4% year-to-date advance now gives it a market capitalization of $3.94 trillion. AAPL's market cap closed today at $3.84 trillion. (For what it's worth, Nvidia is tops at $4.50 trillion.)
The big losses in these mega-cap tech stocks caused the Nasdaq Composite (-0.4% to 23,480) to close in the red, while gains in consumer stocks helped the S&P 500 finish flat at 6,921 and pushed the blue-chip Dow Jones Industrial Average up 0.6% at 49,266.
Track all markets on TradingViewHome Depot, Nike top the Dow
Home Depot (HD) was the second-best Dow stock on Thursday, gaining 3.0%, while Nike (NKE) came in first with its 3.2% advance. NKE rose even after Needham downgraded the athletic apparel and footwear retailer to Hold from Buy.
Track all markets on TradingView"Although we continue to believe that [Nike] CEO Elliott Hill is doing the right things for the brand long-term, we believe that the turnaround is taking longer than expected, and visibility into the turnaround remains low," writes Needham analyst Tom Nikic.
Defense stocks pop on Trump's budget proposal
Defense stocks also saw notable gains Thursday after President Trump called for a $1.5 trillion defense budget.
"I have determined that, for the Good of our Country, especially in these very troubled and dangerous times, our Military Budget for the year 2027 should not be $1 Trillion Dollars, but rather $1.5 Trillion Dollars," Trump wrote on Truth Social. This marks a significant increase to the $901 billion defense budget Congress passed for 2026.
Honeywell International (HON) climbed 2.9%, Lockheed Martin (LMT) rose 4.3% and Kratos Defense & Security Solutions (KTOS) surged 13.8%.
Track all markets on TradingViewJobs data, earnings season on tap
The next few weeks will be busy with a string of economic reports set to be released ahead of the next Fed meeting and fourth-quarter earnings season about to kick off.
First up on the economic calendar is tomorrow morning's release of the December nonfarm payrolls report, which is expected to show lukewarm jobs growth.
Next week, meanwhile, we'll start to see corporate earnings reports start to roll in, with big banks JPMorgan Chase (JPM) and Bank of America (BAC) among those reporting.
Related content
- What the Rich Know About Investing That You Don't
- Best Stocks to Buy Now
- 5 Stocks to Buy for a Trump Presidency
Karee VenemaSocial Links NavigationSenior Investing Editor, Kiplinger.comWith over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
Latest You might also like View More \25b8
What to Watch for When Refinancing Your Home Mortgage
The 10 Best Splurge Destinations for Retirees in 2026
Builders Are Offering Big Mortgage Incentives — What Homebuyers Should Watch For
What Changed on January 1: Check Out These Opportunities Created by the New Tax Law
Beat the Money Blues With This Easy Financial Check-In to Get 2026 Off to a Good Start
Do Self-Storage REITs Deserve Space in Your Portfolio? It's a Yes From This Investment Adviser
Dow Hits a Record High After December Jobs Report: Stock Market Today
The December Jobs Report Is Out. Here's What It Means for the Next Fed Meeting
4 Simple Money Targets to Aim for in 2026 (And How to Hit Them), From a Financial Planner
Estate Planning Isn't Just for the Ultra-Wealthy
How to Be a Smart Insurance Shopper: The Price Might Be Right, But the Coverage Might Not Be